Zhejiang Taimei Medical Technology Co., Ltd. (HKG:2576)
Hong Kong · Delayed Price · Currency is HKD 4.750
+0.070 (1.50%)
Oct 2, 2026, 4:08 PM HKT
HKG:2576 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 531.96 | 512.54 | 551.16 | 573.14 | 549.22 | 466.18 | |
Revenue Growth | 1.79% | -7.01% | -3.84% | 4.36% | 17.81% | 53.88% |
Cost of Revenue | 296.86 | 295 | 326.21 | 394.14 | 363.81 | 301.85 |
Gross Profit | 235.1 | 217.54 | 224.94 | 179 | 185.4 | 164.33 |
Selling, General & Admin | 220.9 | 202.01 | 408.99 | 419.12 | 473.79 | 446.23 |
Research & Development | 80.89 | 78.67 | 87.05 | 169.19 | 208.18 | 190.84 |
Other Operating Expenses | -18.03 | -14.7 | -9.64 | -16.24 | -15.69 | -13.56 |
Operating Expenses | 292.56 | 274.77 | 489.99 | 580.4 | 670.84 | 626.92 |
Operating Income | -57.45 | -57.23 | -265.05 | -401.4 | -485.44 | -462.59 |
Interest Expense | -1.24 | -0.83 | -0.73 | -1.43 | -2.68 | -2.71 |
Interest & Investment Income | 30.87 | 35.65 | 37.05 | 41.65 | 22.88 | 28.74 |
Currency Exchange Gain (Loss) | -42.39 | -29.57 | 17.48 | 8.65 | 54.03 | -7.96 |
Other Non Operating Income (Expenses) | -0.01 | - | - | - | 1.27 | -0.82 |
EBT Excluding Unusual Items | -70.22 | -51.98 | -211.25 | -352.53 | -409.94 | -445.33 |
Impairment of Goodwill | - | - | -9.8 | -8.37 | -22.38 | -54.09 |
Gain (Loss) on Sale of Investments | 0.6 | 1.21 | 3.76 | 5.84 | 9.79 | 19.8 |
Gain (Loss) on Sale of Assets | 0.07 | 0.07 | -0.17 | - | -0.47 | 0.02 |
Asset Writedown | - | - | - | -1.2 | - | - |
Other Unusual Items | - | - | 0.04 | -0.11 | 0.42 | - |
Pretax Income | -69.55 | -50.7 | -217.41 | -356.36 | -422.58 | -479.61 |
Income Tax Expense | - | - | - | 0.02 | - | 0.01 |
Earnings From Continuing Operations | -69.55 | -50.7 | -217.41 | -356.38 | -422.58 | -479.61 |
Minority Interest in Earnings | 4.4 | 7.86 | 2.8 | 9.6 | 9.67 | - |
Net Income | -65.15 | -42.85 | -214.61 | -346.78 | -412.91 | -479.61 |
Net Income to Common | -65.15 | -42.85 | -214.61 | -346.78 | -412.91 | -479.61 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 564 | 564 | 544 | 538 | 538 | 538 |
Shares Outstanding (Diluted) | 564 | 564 | 544 | 538 | 538 | 538 |
Shares Change | 1.23% | 3.65% | 1.10% | - | - | 15.22% |
EPS (Basic) | -0.12 | -0.08 | -0.39 | -0.64 | -0.77 | -0.89 |
EPS (Diluted) | -0.12 | -0.08 | -0.39 | -0.64 | -0.77 | -0.89 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -60.4 | -42.43 | -207.3 | -355.52 | -353.62 | -247.63 |
Free Cash Flow Per Share | -0.11 | -0.07 | -0.38 | -0.66 | -0.66 | -0.46 |
Gross Margin | 44.20% | 42.44% | 40.81% | 31.23% | 33.76% | 35.25% |
Operating Margin | -10.80% | -11.16% | -48.09% | -70.04% | -88.39% | -99.23% |
Profit Margin | -12.25% | -8.36% | -38.94% | -60.50% | -75.18% | -102.88% |
Free Cash Flow Margin | -11.35% | -8.28% | -37.61% | -62.03% | -64.39% | -53.12% |
EBITDA | -51.44 | -50.09 | -248.66 | -378.66 | -463.41 | -451.58 |
EBITDA Margin | -9.67% | -9.77% | -45.12% | -66.07% | -84.38% | -96.87% |
D&A For EBITDA | 6.01 | 7.14 | 16.39 | 22.74 | 22.03 | 11 |
EBIT | -57.45 | -57.23 | -265.05 | -401.4 | -485.44 | -462.59 |
EBIT Margin | -10.80% | -11.16% | -48.09% | -70.04% | -88.39% | -99.23% |